HIGHLIGHTS
- who: Myo Myo Aung and collaborators from the University of Medical School, Barrack Road, AX, UK have published the research work: Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes, in the Journal: (JOURNAL)
- what: This research examined the microvascular actions of the and exenatide in individuals with and without type diabetes (study It also explored the involvement of the receptor (study and the pathway in mediating the microvascular effects of the Methods Trial design: Studies and had a randomised controlled double-blind study design . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.